We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of CKPT yet.

CKPT Hedge Fund Activity: Q2 2025 in Review

0 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2025, worth a combined $0 — down 100% from $138M a quarter earlier.

Sellers outnumbered buyers: 83 funds closed out of CKPT and 0 opened new positions — a net loss of 83 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Beryl Capital Management, exiting entirely with an estimated $24.5M sold.

  • 0 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2025, down from 84 in Q1 2025.
  • Funds reported $0 of Checkpoint Therapeutics stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Checkpoint Therapeutics positions in Q2 2025 and 83 closed out, a net change of -83 holders.
  • The largest Checkpoint Therapeutics seller in Q2 2025 was Beryl Capital Management, an estimated $24.5M sold.

Based on aggregated 13F filings for Q2 2025.